about
Elevated peripheral eosinophils are associated with new-onset and persistent wheeze and airflow obstruction in World Trade Center-exposed individualsOne airway: biomarkers of protection from upper and lower airway injury after World Trade Center exposureRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with salmeterol for chronic asthma: serious adverse eventsSubstrates and products of eosinophil peroxidaseChemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibodyDefinition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individualsPractical approach to the patient with hypereosinophiliaRole of airway lactoperoxidase in scavenging of hydrogen peroxide damage in asthmaEosinophils in the 1990s: new perspectives on their role in health and diseaseMolecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophilsEotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammationAirway allergen exposure stimulates bone marrow eosinophilia partly via IL-9.Modulation of Immune Functions by FoodsPrenatal dichlorodiphenyldichloroethylene (DDE) and asthma in childrenAntigen-sensitized CD4+CD62Llow memory/effector T helper 2 cells can induce airway hyperresponsiveness in an antigen free settingDiagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytologyClinical usefulness of mepolizumab in severe eosinophilic asthmaBenralizumab: a unique IL-5 inhibitor for severe asthmaEstrogen Signaling Modulates Allergic Inflammation and Contributes to Sex Differences in AsthmaThe past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review.Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseasesChemokines and immunityEosinophil apoptosis and clearance in asthmaAnti-IL5 therapy for asthma and beyondAirway smooth muscle in asthma: just a target for bronchodilation?p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway InflammationSevere asthma: anti-IgE or anti-IL-5?Management of the patient with eosinophilic asthma: a new era begins11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophilsStimulation of human bronchial epithelial cells by IgE-dependent histamine-releasing factorHeme oxygenase-1: the "emerging molecule" has arrivedEosinophil cationic protein stimulates migration of human lung fibroblasts in vitroInterleukin-13: central mediator of allergic asthmaAutocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscleInterleukin-5 in growth and differentiation of blood eosinophil progenitors in asthma: effect of glucocorticoidsHypersensitivity of pulmonary C fibre afferents induced by cationic proteins in the ratMolecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophilsEtiology and pathogenesis of airway disease in children and adults from rural communities
P2860
Q23909921-5CE8443A-AE48-4387-8AA7-895F0D1E8B4FQ24170161-96817E2A-445E-499F-915C-D7BD1CB64647Q24200353-B9DCA6C8-25AB-40D6-B583-496AEF5D452BQ24241250-4961C449-37E5-457C-88C3-46F5F7A45125Q24241960-7ABEB639-F98E-4CF6-A7FF-EEDE51E1B924Q24533401-DA38A9CA-1C8C-450A-AD69-226E8960EA08Q24561853-35941E10-BC8A-443A-B3FB-866C43E551DBQ24595853-BAF100CB-8BEF-42B0-8B3B-B7AEF722ED64Q24610994-17AF1825-EB8C-4F44-9669-0451C7E09AEDQ24647000-D74897A2-1B6C-484F-A2B9-1174D9903D55Q24648898-AC86A0CE-02D2-4A59-8AB3-7CCC1094E3EFQ24678192-361112F2-6D56-482A-AA2B-CFD7E4BC3446Q24680123-73510DFB-862B-4BF7-92A9-25C178C7E86FQ24800600-8E7AD67A-1A36-4C9C-9D5D-9CB445DC0D7FQ24808820-321F9C28-D29A-4432-B714-3A2C40F9E2A0Q24811843-C93EB9EA-220D-4B2F-B6E3-C63A454027AEQ24814571-3E08FCA4-8E56-4CF6-BE06-FDEC6365A77FQ26744274-ABA63B3B-2D03-468E-BB02-C2CBE4B48629Q26746215-0E9C52E6-2FF3-4339-847D-722D049087D0Q26750711-CAE6CA86-9AF6-4990-8D2A-B880115C84A7Q26774684-994C376F-1801-43D1-A31B-34E9A1B8D967Q26775861-79F861D0-8F42-42E2-89F9-14CAB1AB6DB3Q26778683-CD33187B-A031-4C84-AAC3-BD2F26272B92Q26783152-40D3F063-2273-48D3-B700-EA68415619ABQ26852263-94B18A71-8B1F-4257-8211-7997E131F8C2Q26866943-35368CFC-0DBF-492F-BF4E-E51AC728838DQ27023298-AB7D4AAF-1303-49CA-BDE1-F97EC98E05D0Q27334428-5E2D1708-CEF0-4CA4-97F4-8388A6CB6F8BQ28071832-1C083CB4-1920-4ED2-B1A0-9859F4C2EFB2Q28078191-853B496E-1D49-471B-A631-4F2C245BE066Q28190702-D44F74B5-3D49-47A5-891A-7CE82A0BAD05Q28204387-F76A3414-5E8D-4B71-A8A8-F9CD8EF2BF4DQ28207978-6D457E26-0FBC-42C7-875C-0B8CC4EC8CEFQ28238081-DCD63910-9DF8-4999-96EA-16B334A49D95Q28291712-0DB7DCBA-FEA6-407F-B3D7-9EC36AD0BDB9Q28343578-2779B378-B892-474D-954E-6143A6C154AEQ28365422-23EEC3A2-3347-4816-BBD9-5454E7295BE4Q28366523-5286A0DD-9B53-4C3B-BC0C-D92EA10DED24Q28368966-955D0E79-79E0-4C88-A5CF-38014BC87741Q28390466-8135ED25-D48D-409D-A22D-298F04182D64
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Eosinophilic Inflammation in Asthma
@ast
Eosinophilic Inflammation in Asthma
@en
type
label
Eosinophilic Inflammation in Asthma
@ast
Eosinophilic Inflammation in Asthma
@en
prefLabel
Eosinophilic Inflammation in Asthma
@ast
Eosinophilic Inflammation in Asthma
@en
P2093
P3181
P1476
Eosinophilic Inflammation in Asthma
@en
P2093
François-Bernard Michel
Gilbert Barnéon
Ingrid Enander
Jean Bousquet
Jean Yves Lacoste
Joelle Simony-Lafontaine
Nouchine Ghavanian
Pascal Chanez
Philippe Godard
P304
P3181
P356
10.1056/NEJM199010113231505
P407
P577
1990-10-11T00:00:00Z